• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pheochromocytoma in Sweden 1958-1981. An analysis of the National Cancer Registry Data.

作者信息

Stenström G, Svärdsudd K

出版信息

Acta Med Scand. 1986;220(3):225-32.

PMID:3776697
Abstract

An epidemiological study of 439 cases (184 males, 255 females) of pheochromocytoma (paraganglioma) diagnosed in Sweden from 1958-81 is presented. From the mid 1960's an average of 22 cases have been diagnosed each year. In 255 cases, the pheochromocytoma was diagnosed by clinical examination and/or surgery. In 184 cases (40%), the diagnosis was achieved by autopsy and out of which 60 (14% of all cases) were reported as incidental findings. Ninety-five pheochromocytomas (22%) were located outside the adrenals. The average (+/- SD) age at diagnosis for the total study population was 55.8 +/- 17.7 years. Clinically diagnosed tumour cases were significantly younger (48.5 +/- 16.3 years) compared to cases diagnosed at autopsy (65.8 +/- 14.0). Pheochromocytomas were more common among women than among men. The age specific incidence rate increased continuously for both sexes from the youngest to the oldest age groups. The average incidence of pheochromocytoma in the 24 counties of Sweden was 2.1 cases per million inhabitants per year, range 0.9-5.3. A North to South gradient was noted with a higher incidence in the Southern parts of the country. Whether this is due to a real geographical variation of incidence, to a larger number of unreported cases in the Northern parts, or to presence of families with Sipple's syndrome in the South is unclear.

摘要

相似文献

1
Pheochromocytoma in Sweden 1958-1981. An analysis of the National Cancer Registry Data.
Acta Med Scand. 1986;220(3):225-32.
2
[Pheochromocytoma--pathohistologic and immunohistochemical aspects].[嗜铬细胞瘤——病理组织学和免疫组织化学方面]
Srp Arh Celok Lek. 2002 Jul;130 Suppl 2:7-13.
3
[Personal experience in diagnosis and localization of pheochromocytoma].[嗜铬细胞瘤诊断与定位的个人经验]
Srp Arh Celok Lek. 2002 Jul;130 Suppl 2:14-9.
4
Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population.瑞典特定人群中1型神经纤维瘤病患者的恶性和良性肿瘤
Cancer. 1997 Jun 1;79(11):2125-31.
5
[Pheochromocytoma: 25 years of experience. Report of 199 cases].
Arch Mal Coeur Vaiss. 2003 Oct;96(10):963-6.
6
NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).酚酞(CAS编号:77-09-8)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学和致癌性研究(饲料研究)
Natl Toxicol Program Tech Rep Ser. 1996 Nov;465:1-354.
7
[Results of surgical treatment of pheochromocytoma at the Institute of Endocrinology of the Clinical Center of Serbia in Belgrade].[塞尔维亚贝尔格莱德临床中心内分泌研究所嗜铬细胞瘤的外科治疗结果]
Srp Arh Celok Lek. 2002 Jul;130 Suppl 2:38-42.
8
Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.口腔和口咽鳞状细胞癌的危险因素:瑞典南部一项基于人群的病例对照研究。
Swed Dent J Suppl. 2005(179):1-66.
9
Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979.1950年至1979年明尼苏达州罗切斯特市嗜铬细胞瘤的发病情况。
Mayo Clin Proc. 1983 Dec;58(12):802-4.
10
NTP Toxicology and Carcinogenesis Studies of Nickel Oxide (CAS No. 1313-99-1) in F344 Rats and B6C3F1 Mice (Inhalation Studies).氧化镍(CAS编号:1313-99-1)在F344大鼠和B6C3F1小鼠中的NTP毒理学与致癌性研究(吸入研究)
Natl Toxicol Program Tech Rep Ser. 1996 Jul;451:1-381.

引用本文的文献

1
Screening for endocrine hypertension in China: protocol for a multicentre prospective cohort study.中国内分泌性高血压筛查:一项多中心前瞻性队列研究方案
BMJ Open. 2025 Aug 31;15(8):e098446. doi: 10.1136/bmjopen-2024-098446.
2
Global epidemiology of pheochromocytoma: a systematic review and meta-analysis of observational studies.嗜铬细胞瘤的全球流行病学:观察性研究的系统评价和荟萃分析
J Endocrinol Invest. 2025 Jul 2. doi: 10.1007/s40618-025-02639-9.
3
PGL-EXPO feasibility study of exposure to SDHi fungicides and risk of hereditary SDHx paraganglioma or pheochromocytoma.
PGL-EXPO:接触琥珀酸脱氢酶抑制剂类杀菌剂与遗传性琥珀酸脱氢酶基因(SDHx)相关副神经节瘤或嗜铬细胞瘤风险的可行性研究
Sci Rep. 2025 Jul 2;15(1):22716. doi: 10.1038/s41598-025-09166-w.
4
Sex differences in presentation of pheochromocytoma and paraganglioma.嗜铬细胞瘤和副神经节瘤临床表现中的性别差异。
Front Endocrinol (Lausanne). 2025 Jan 23;16:1463945. doi: 10.3389/fendo.2025.1463945. eCollection 2025.
5
SWEET'S SYNDROME ASSOCIATED WITH PHEOCHROMOCYTOMA: A RARE CASE REPORT AND REVIEW OF LITERATURE.伴发嗜铬细胞瘤的斯威特综合征:1例罕见病例报告及文献复习
Acta Endocrinol (Buchar). 2024 Apr-Jun;20(2):222-230. doi: 10.4183/aeb.2024.222. Epub 2025 Jan 18.
6
Evaluation of pharmacokinetics, safety, and efficacy of [211At] meta-astatobenzylguanidine ([211At] MABG) in patients with pheochromocytoma or paraganglioma (PPGL): A study protocol.[211At]meta-astatobenzylguanidine([211At]MABG)在嗜铬细胞瘤或副神经节瘤(PPGL)患者中的药代动力学、安全性和疗效评价:一项研究方案。
PLoS One. 2024 May 28;19(5):e0303623. doi: 10.1371/journal.pone.0303623. eCollection 2024.
7
Case of functional paraganglioma with intraoperative hypertensive crisis during robot-assisted thoracoscopic resection.机器人辅助胸腔镜切除术中功能性副神经节瘤伴术中高血压危象病例
Surg Case Rep. 2024 May 22;10(1):127. doi: 10.1186/s40792-024-01930-w.
8
Anlotinib for Metastatic Progressed Pheochromocytoma and Paraganglioma: A Retrospective Study of Real-World Data.安罗替尼用于转移性进展性嗜铬细胞瘤和副神经节瘤:真实世界数据的回顾性研究
J Endocr Soc. 2024 Apr 2;8(6):bvae061. doi: 10.1210/jendso/bvae061. eCollection 2024 Apr 6.
9
Biochemically Silent Pheochromocytoma in an Asymptomatic Patient With a Unilateral Lipid-Poor Adrenal Adenoma.无症状单侧低脂肾上腺腺瘤患者的生化隐匿性嗜铬细胞瘤
Cureus. 2023 Oct 16;15(10):e47120. doi: 10.7759/cureus.47120. eCollection 2023 Oct.
10
Pheochromocytoma: a changing perspective and current concepts.嗜铬细胞瘤:不断变化的观点与当前概念
Ther Adv Endocrinol Metab. 2023 Oct 29;14:20420188231207544. doi: 10.1177/20420188231207544. eCollection 2023.